Vimian Group AB/Skr VIMIAN
07:00
09:05
11:15
13:20
15:25
1D1W1MYTD1Y5YMAX
About Vimian Group AB
Vimian Group AB operates in the veterinary services industry, focusing on providing a range of specialized products and solutions for animal health. The company offers products and services across four key segments: Specialty Pharma, Diagnostics, Veterinary Services, and MedTech. These segments provide pharmaceuticals, diagnostic equipment, technology solutions, and veterinary services aimed at enhancing animal health and treatment. Founded in Sweden, Vimian Group AB is headquartered in Stockholm, from where it extends its operations globally. The company's strategic positioning is strengthened by its comprehensive range of products and services, allowing it to address diverse needs in the veterinary sector and support veterinarians through innovative solutions.
Ticker
Skr VIMIAN
Sector
Primary listing
XSTO
Employees
1,300
Headquarters
Stockholm, Sweden
Website
Vimian Group AB Metrics
BasicAdvanced
kr 18bn
44.52
kr 0.76
1.17
-
Price and volume
Market cap
kr 18bn
Beta
1.17
52-week high
kr 35.45
52-week low
kr 24.18
Average daily volume
275k
Financial strength
Current ratio
2.434
Quick ratio
1.348
Long term debt to equity
36.7
Total debt to equity
37.398
Interest coverage (TTM)
4.53%
Profitability
EBITDA (TTM)
1,252.234
Gross margin (TTM)
68.82%
Net profit margin (TTM)
8.16%
Operating margin (TTM)
17.96%
Effective tax rate (TTM)
30.46%
Revenue per employee (TTM)
kr 3,837,840
Management effectiveness
Return on assets (TTM)
4.36%
Return on equity (TTM)
5.27%
Valuation
Price to earnings (TTM)
44.522
Price to revenue (TTM)
3.634
Price to book
24.61
Price to tangible book (TTM)
-135.06
Price to free cash flow (TTM)
22.141
Free cash flow yield (TTM)
4.52%
Free cash flow per share (TTM)
1.536
Growth
Revenue change (TTM)
11.53%
Earnings per share change (TTM)
74.11%
3-year revenue growth (CAGR)
12.61%
3-year earnings per share growth (CAGR)
28.86%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.